Travere Therapeutics (TVTX) Change in Receivables (2014 - 2026)
Travere Therapeutics' Change in Receivables was $41.92 million in Q3 2026, down 5.1% from $44.16 million a year earlier.
Travere Therapeutics (TVTX) Change in Receivables (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Travere Therapeutics' Change in Receivables was $14.69 million through Sep 30, 2026, down 74.5% year-over-year; for FY2025, it was $27.82 million, up 363.6% from FY2024.
- In earlier years, Change in Receivables was $6 million in FY2024 (-46.7%), $11.26 million in FY2023 (+962.6%), $1.06 million in FY2022 and -$853,000 in FY2021.
- Quarterly Change in Receivables has moved between -$27.82 million (Q4 2025) and $44.16 million (Q3 2025) over five years.
- Compared with a year earlier, Change in Receivables was higher in three of the last five quarters, with growth averaging 86.4%.
- The best year-over-year quarter for Change in Receivables over five years was Q1 2025 (growth of 365.7%); the worst was Q4 2024 (a decline of 75.1%).
- Per Business Quant data, TVTX's Change in Receivables in the three quarters before Q3 2026 was -$6.64 million (Q2 2026), $7.23 million (Q1 2026) and -$27.82 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -188.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -312.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 108.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -52.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | 41.92 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 41.92 Mn |
| Jun 30, 2026 | -6.64 Mn |
| Mar 31, 2026 | 7.23 Mn |
| Dec 31, 2025 | -27.82 Mn |
| Sep 30, 2025 | 44.16 Mn |
| Jun 30, 2025 | 4.28 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 731,000.00 |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 7.97 Mn |
| Sep 30, 2023 | -785,000.00 |
| Jun 30, 2023 | -578,000.00 |
| Mar 31, 2023 | 4.66 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | -5.72 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | -1.24 Mn |
| Dec 31, 2021 | 1.72 Mn |
Travere Therapeutics Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TVTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();